• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚需要一个疫苗伤害赔偿计划:即将推出的新冠疫苗使引入该计划变得紧迫。

Australia needs a vaccine injury compensation scheme: Upcoming COVID-19 vaccines make its introduction urgent.

作者信息

Wood Nicholas, Macartney Kristine, Leask Julie, McIntyre Peter

机构信息

MBBS, PhD, FRACP, Senior Staff Specialist, National Centre for Immunisation Research and Surveillance, The Children@s Hospital at Westmead, NSW; Associate Professor, The University of Sydney Children@s Hospital Westmead Clinical School, NSW.

MD, FRACP, Professor, Faculty of Medicine and Health, The University of Sydney, NSW; Director, The National Centre for Immunisation Research and Surveillance (NCIRS), NSW.

出版信息

Aust J Gen Pract. 2020 Sep 9;49. doi: 10.31128/AJGP-COVID-36.

DOI:10.31128/AJGP-COVID-36
PMID:33051635
Abstract

There is a strong public health ethical justification to introduce a vaccine injury compensation scheme in Australia, and it needs to be in place before widespread use of COVID-19 vaccines.

摘要

在澳大利亚引入疫苗伤害补偿计划有很强的公共卫生伦理依据,并且该计划需要在新冠疫苗广泛使用之前到位。

相似文献

1
Australia needs a vaccine injury compensation scheme: Upcoming COVID-19 vaccines make its introduction urgent.澳大利亚需要一个疫苗伤害赔偿计划:即将推出的新冠疫苗使引入该计划变得紧迫。
Aust J Gen Pract. 2020 Sep 9;49. doi: 10.31128/AJGP-COVID-36.
2
Chasing Immunity: How Viable Is a Mandatory COVID-19 Vaccination Scheme for Australia?追逐免疫力:澳大利亚强制性 COVID-19 疫苗接种计划可行吗?
J Law Med. 2021 Mar;28(3):718-733.
3
COVAX no fault compensation program for COVID-19 vaccine injuries in 92 low and middle income countries.针对92个低收入和中等收入国家新冠疫苗接种损伤的COVAX无过错补偿计划。
Vaccine. 2021 Dec 3;39(49):7128-7130. doi: 10.1016/j.vaccine.2021.10.047. Epub 2021 Oct 28.
4
Current situation of vaccine injury compensation program and a future perspective in light of COVID-19 and emerging viral diseases.从 COVID-19 和新发病毒性疾病的角度看疫苗损伤赔偿计划的现状和未来展望。
F1000Res. 2021 Jul 26;10:652. doi: 10.12688/f1000research.51160.2. eCollection 2021.
5
SARS-CoV-2 vaccines-induced thrombotic thrombocytopenia: should we consider immuno-hypersensitivity?SARS-CoV-2 疫苗诱导的血栓性血小板减少症:我们是否应考虑免疫超敏反应?
Rev Saude Publica. 2021 Oct 29;55:70. doi: 10.11606/s1518-8787.2021055003855. eCollection 2021.
6
Safety Surveillance of COVID-19 mRNA Vaccines Through the Vaccine Safety Datalink.通过疫苗安全数据链对新冠病毒mRNA疫苗进行安全性监测。
JAMA. 2021 Oct 12;326(14):1375-1377. doi: 10.1001/jama.2021.14808.
7
SARS-CoV-2: Unique Challenges of the Virus and Vaccines.SARS-CoV-2:病毒和疫苗的独特挑战。
Immunol Invest. 2021 Oct;50(7):802-809. doi: 10.1080/08820139.2021.1936009. Epub 2021 Jun 10.
8
COVID-19 vaccine-induced thrombosis.新型冠状病毒肺炎疫苗诱导的血栓形成
Int J Tuberc Lung Dis. 2021 Sep 1;25(9):691-692. doi: 10.5588/ijtld.21.0389.
9
Behavioral and social science in support of SARS-CoV-2 vaccination: National Institutes of Health initiatives.支持 SARS-CoV-2 疫苗接种的行为和社会科学:美国国立卫生研究院的举措。
Transl Behav Med. 2021 Jul 29;11(7):1354-1358. doi: 10.1093/tbm/ibab067.
10
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗:辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.

引用本文的文献

1
Shoulder injury related to vaccine administration (SIRVA): What do we know about its incidence and impact?疫苗接种相关肩部损伤(SIRVA):我们对其发病率和影响了解多少?
Explor Res Clin Soc Pharm. 2022 Sep 26;8:100183. doi: 10.1016/j.rcsop.2022.100183. eCollection 2022 Dec.
2
Key lessons from the COVID-19 public health response in Australia.澳大利亚应对新冠疫情公共卫生措施的关键经验教训。
Lancet Reg Health West Pac. 2023 Jan;30:100616. doi: 10.1016/j.lanwpc.2022.100616. Epub 2022 Oct 10.
3
From program suspension to the pandemic: A qualitative examination of Australia's vaccine pharmacovigilance system over 10 years.
从项目暂停到疫情:对澳大利亚疫苗药物警戒系统 10 年来的定性研究
Vaccine. 2021 Sep 24;39(40):5968-5981. doi: 10.1016/j.vaccine.2021.07.059. Epub 2021 Aug 8.